Netmeds First Membership
Quick Links
Introduction About FERINJECT 1000 INJECTION
FERINJECT 1000 INJECTION contains Ferric carboxymaltose, which belongs to the group of medicines called Iron replacement medicines. It is used to manage iron deficiency anaemia (IDA) in adults and in children (above 14 years of age) who are unable to take iron supplements orally, have an intolerance to oral iron supplements, need a rapid iron supplement in the body, or have non-dialysis-dependent chronic kidney disease.
Iron deficiency anaemia is a condition in which the body lacks enough amount of iron, which is essential for the production of red blood cells and transport of oxygen in the body.
Your doctor may advise you to take relevant tests to understand your existing condition. Before receiving FERINJECT 1000 INJECTION, inform your doctor if you are pregnant, planning to get pregnant, or breastfeeding.
FERINJECT 1000 INJECTION is not recommended for use in children and adolescents (under 14 years of age), and it should be used with caution in elderly patients (aged 65 years or above). Consult your doctor before receiving FERINJECT 1000 INJECTION.
The most common side effects of receiving FERINJECT 1000 INJECTION may include headache, dizziness, flushing, high blood pressure, nausea, and injection or infusion site reactions. Consult your physician if any of the symptoms worsen.
Uses Of FERINJECT 1000 INJECTION
- Manages iron deficiency anaemia
Benefits of FERINJECT 1000 INJECTION
1. Enables Rapid Iron Repletion
- Ferinject contains ferric carboxymaltose, a formulation that allows delivery of high-dose iron in a single sitting, helping achieve faster iron replenishment when oral iron is not suitable.
2. Designed for Patients Who Cannot Tolerate Oral Iron
- The injection bypasses the digestive system, making it useful for individuals who experience gastric discomfort or poor absorption from oral iron supplements.
3. Allows Large Single-Dose Administration (Up to 1000 mg)
- The formulation is engineered to be safely infused in larger quantities than many other IV iron products, reducing the need for multiple hospital visits.
4. Stable Complex for Controlled Iron Release
- The carboxymaltose shell keeps iron stable and allows gradual release, reducing the risk of free-iron reactions.
5. Suitable for Hospital or Supervised Clinical Use
- Given under medical supervision, ensuring accurate dosing and safe monitoring
How FERINJECT 1000 INJECTION Works
1. Administered Intravenously Only
- Ferinject is given through an IV route—either as a slow injection or infusion.
2. Dose Determined by Healthcare Provider
- The amount depends on the patient’s hemoglobin levels, iron deficit calculation, and body weight.
- Maximum single sitting dose of ferric carboxymaltose is often up to 1000 mg, but final dosing depends entirely on medical assessment.
3. Given as an Infusion or Slow IV Push
- IV infusion: Diluted in normal saline and administered over a prescribed time (commonly 15 minutes or longer depending on dose).
- IV push: May be given undiluted at a controlled rate in some settings.
4. Monitoring During Administration
- Vital signs are monitored while the infusion is ongoing.
- Observation continues after completion to ensure tolerance.
5. Dilution & Handling Guidelines (Professional Use Only)
- Dilution is done in compatible fluids like 0.9% sodium chloride.
- It is never mixed with other injectable products.
- Special precautions are taken to maintain aseptic technique.
How to use FERINJECT 1000 INJECTION
1. Ferric Carboxymaltose Delivers Iron in a Highly Stable Complex
- The formulation contains iron(III) hydroxide tightly bound within a carboxymaltose shell.
- This shell prevents free iron release in the bloodstream, reducing oxidative reactions.
2. Controlled Release of Bioavailable Iron
- After injection, the complex is taken up by the reticuloendothelial system (RES)—primarily in the liver, spleen, and bone marrow.
- Macrophages gradually break down the shell, releasing usable iron.
3. Iron Becomes Available for Hemoglobin and Enzyme Production
- Released iron binds to transferrin, the transport protein.
- Transferrin carries iron to:
- Bone marrow → supports formation of new red blood cells
- Muscles → used to form myoglobin
- Cells → supports essential cellular enzymes requiring iron
4. Efficient Uptake Without Gastrointestinal Processing
- Since the iron is delivered directly to systemic circulation, absorption issues associated with oral iron (inflammation, malabsorption, gastric interactions) are bypassed.
5. Higher Iron Availability in a Shorter Time
- The stable structure allows higher single doses without sudden iron spikes, giving steady availability for physiological processes.
Overdose
FERINJECT 1000 INJECTION will be administered to you only by a doctor or a nurse in a hospital, and so it is unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual symptoms.
Side Effects Of FERINJECT 1000 INJECTION
Common
- Headache
- Dizziness
- Flushing
- High blood pressure
- Nausea
- Injection/infusion site reactions
- Low levels of phosphorous in the blood
When to consult a doctor:
- Symptoms of serious allergic reaction or Kounis syndrome (such as rashes, itching, swelling of the face, lips, mouth, tongue, throat, or body causing difficulty in breathing or wheezing and chest pain)
- Severe or life-threatening allergic reactions called anaphylactic reactions, which can be associated with heart problems, circulation problems (low blood pressure), and loss of consciousness
- Sign of a decrease in blood phosphorus causing softening of bones (osteomalacia). Symptoms include worsening of tiredness, muscle or bone pain (pain in arms or legs, joints, or back), and may lead to fractures
- Signs of high blood pressure (such as facial flushing, dizziness, or nausea)
- Skin irritation and brownish discolouration of the skin at the injected site
Warning & Precautions
Pregnancy
Use with CautionFERINJECT 1000 INJECTION should be used with caution in pregnant women only if considered clearly necessary. Inform your doctor if you are pregnant, think you may be pregnant, or are planning to have a baby. Consult your doctor.
Breastfeeding
Consult your doctorIf you are breastfeeding, consult your doctor for advice before receiving FERINJECT 1000 INJECTION. It is unlikely that FERINJECT 1000 INJECTION represents a risk to the breastfed child.
Driving and Using Machines
Use with CautionFERINJECT 1000 INJECTION is unlikely to impair the ability to drive or operate machines.
Kidney
Use with CautionFERINJECT 1000 INJECTION should be used with caution in patients with chronic kidney disease who are dependent on haemodialysis management. Consult your doctor before receiving
Liver
Use with CautionFERINJECT 1000 INJECTION should be used with caution in patients with liver disease. Consult your doctor.
Allergy
ContraindicatedDo not receive FERINJECT 1000 INJECTION if you are allergic to ferric carboxymaltose or any of the other ingredients of this medicine or if you have experienced serious allergic reactions to other injectable iron preparations.
Lungs
Use with CautionFERINJECT 1000 INJECTION should be used with caution in patients with severe asthma. Consult your doctor before receiving FERINJECT 1000 INJECTION.
Use In Pediatrics
ContraindicatedFERINJECT 1000 INJECTION is not recommended for use in children (under 14 years of age). Consult the child's doctor for advice on how to manage the condition.
Use In Geriatrics
Use with CautionFERINJECT 1000 INJECTION should be used with caution in elderly patients (aged 65 years or above). Consult your doctor before receiving FERINJECT 1000 INJECTION.
Other Warnings for FERINJECT 1000 INJECTION
Before receiving FERINJECT 1000 INJECTION, inform your doctor if you have:
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Eczema or other allergies
- An infection
- Low levels of phosphate in the blood
- High blood pressure
Who should not take FERINJECT 1000 INJECTION
FERINJECT 1000 INJECTION is not recommended for use if you have:
- Anaemia not caused by iron deficiency
- Iron overload (too much iron in your body) or disturbances in the utilization of iron
Drug - Drug interaction
1. Oral Iron Supplements
Examples: ferrous sulfate, ferrous fumarate, ferrous gluconate
- Taking oral iron at the same time may reduce absorption of the oral tablets.
- Healthcare providers generally advise pausing oral iron for a few days before and after the injection.
2. Medicines That Affect Iron Levels
Examples: iron-containing multivitamins, iron tonic formulations
- Combining multiple iron products may lead to excess iron accumulation, so such combinations are avoided unless medically justified.
3. ACE Inhibitors
Examples: enalapril, ramipril, lisinopril
- These medicines may increase the likelihood of injection-related reactions, such as flushing or blood pressure changes.
- Monitoring is recommended during and after administration.
4. Medicines That Influence Immune or Allergy Responses
Examples: antihistamines, corticosteroids, monoclonal antibodies
- These medicines do not directly interact with the iron complex but may mask mild allergic reactions, requiring cautious supervision during infusion.
5. Drugs With Risk of Hypotension
Examples: nitrates, certain antihypertensives
- Ferinject may occasionally cause transient drops in blood pressure, and combining it with BP-lowering drugs may intensify this effect.
6. Medicines That Affect Phosphate Levels
Examples: phosphate binders used in kidney conditions
- Ferric carboxymaltose may influence phosphate metabolism, so concurrent use with such medicines requires monitoring.
7. IV Iron Products (Other Formulations)
Examples: iron sucrose, iron dextran, ferric gluconate
- Using more than one form of IV iron simultaneously is not recommended because stability profiles differ and may raise the risk of iron overload.
8. Antibiotics That Bind Metal Ions
Examples: tetracyclines, quinolones
- These interactions occur mainly with oral iron, but spacing may still be suggested to avoid interference with absorption logistics for oral forms taken post-procedure.
Synopsis
| Drug | : | Ferric carboxymaltose |
| Pharmacological Category | : | Iron replacement medicines |
| Therapeutic Indication | : | Iron Deficiency Anemia (IDA) |
| Dosage Forms | : | Injection |
More Information
1. Explanation of Iron Mobilization After Administration
After infusion:
- The complex circulates in the plasma.
- Iron is gradually released from the core.
- The body’s reticuloendothelial system (especially liver and spleen macrophages) takes up the complex.
- Iron is incorporated into ferritin for storage, then into hemoglobin-building pathways as required.
2. Clinical Contexts Where IV Iron Is Considered
- IV iron is commonly used when rapid replenishment of iron stores is preferred by clinicians.
- It may be part of treatment pathways where oral iron is not tolerated, absorption is impaired, or iron needs exceed what oral supplements can provide.
- IV iron is often administered in hospital day-care units or infusion centers, where staff can monitor vitals and infusion parameters.
3.Pharmacokinetic Characteristics
- The complex has a low level of immediate free iron, which is why the iron release is gradual.
- Peak iron levels typically occur within 15 minutes after infusion completion (general scientific value, not therapeutic claim).
- The half-life of the complex allows for controlled availability of iron over several days.
- It is eventually metabolized through mechanisms involving the mononuclear phagocyte system.
4. What Healthcare Professionals Check Before Administration
- History of prior reactions to IV iron preparations.
- Evaluation for potential iron overload conditions.
- Recent laboratory results including CBC, ferritin, and iron indices.
- Presence of active infections or inflammatory conditions may also be reviewed.
"Did you know?"
- IV iron does not replace the need for a balanced diet; it complements medical treatment.
- Not all iron deficiency states require IV iron; formulation choice is medical-judgment based.
- IV iron is not self-administered; trained professionals must handle the dilution and infusion.
FAQs About FERINJECT 1000 INJECTION
Q: What is the use of FERINJECT 1000 INJECTION?
A: FERINJECT 1000 INJECTION is used to correct iron deficiency anaemia (IDA) in adults and in children (above 14 years of age).
Q: How long does it take for FERINJECT 1000 INJECTION to improve hemoglobin levels?
A: It takes a few weeks for FERINJECT 1000 INJECTION to improve your hemoglobin levels, but some people may notice an improvement in their symptoms within a few days.
Q: How does FERINJECT 1000 INJECTION work?
A: FERINJECT 1000 INJECTION contains iron (III) hydroxide complexed with a carbohydrate polymer called carboxymaltose, which is capable of releasing iron. The iron released from the complex helps in the synthesis of haemoglobin and increases red blood cell count. As a result, it manages iron deficiency anaemia.
Q: Is FERINJECT 1000 INJECTION safe to use in patients with liver problems?
A: FERINJECT 1000 INJECTION should be used with caution in patients with liver disease. Consult your doctor before receiving it.
Q: What are the common side effects of FERINJECT 1000 INJECTION?
A: The most common side effects of using FERINJECT 1000 INJECTION may include headache, dizziness, flushing, high blood pressure, nausea, and injection or infusion site reactions. Consult your physician if any of the symptoms worsen.
Q: Is FERINJECT 1000 INJECTION safe to use in patients with kidney problems?
A: FERINJECT 1000 INJECTION should be used with caution in patients with chronic kidney disease who are dependent on haemodialysis management. Consult your doctor before receiving it.
Q: Who should avoid receiving FERINJECT 1000 INJECTION ?
A: FERINJECT 1000 INJECTION is not recommended for use in patients with evidence of iron overload or disturbances in the utilization of iron, anaemia not attributed to iron deficiency (microcytic anaemia) and with known allergies to ferric carboxymaltose or serious allergies to other parenteral iron products.
Q: Is FERINJECT 1000 INJECTION safe to use in elderly patients?
A: FERINJECT 1000 INJECTION should be used with caution in elderly patients (aged 65 years or above). Your doctor may monitor you carefully during administration and a certain time after administration of FERINJECT 1000 INJECTION.
Q: Can FERINJECT 1000 INJECTION be used during pregnancy?
A: FERINJECT 1000 INJECTION should be used with caution in pregnant women only if clearly advised by your doctor. Inform your doctor if you are pregnant, think you may be pregnant, or are planning to have a baby.
Q: Does FERINJECT 1000 INJECTION affect my ability to drive?
A: FERINJECT 1000 INJECTION is unlikely to impair the ability to drive or operate machines.
Q: Can FERINJECT 1000 INJECTION cause nausea and vomiting?
A: Yes, FERINJECT 1000 INJECTION causes nausea and vomiting. Stick to simple meals. Avoid eating oily, fried, or spicy foods. Do not lie down or sleep immediately after eating. Consult your doctor if the symptom does not improve.
Q: Is FERINJECT 1000 INJECTION safe to use in patients with lung problems?
A: FERINJECT 1000 INJECTION should be used with caution in patients with severe asthma. Consult your doctor before receiving.
Q: Can I take other medicines with FERINJECT 1000 INJECTION ?
A: Before using FERINJECT 1000 INJECTION , inform your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription, vitamin supplements, or herbal products.
Q: Can FERINJECT 1000 INJECTION cause an allergic reaction?
A: Yes, do not receive FERINJECT 1000 INJECTION if you are allergic to ferric carboxymaltose or any of the other ingredients of this medicine or if you have experienced serious allergic reactions to other injectable iron preparations.
References
1. KD. Tripathi. Haematinics and Erythropoietin. Essentials of Medical Pharmacology. Seventh Edition. 2013. Page – 605
2. Joao Ricardo Friedrischa and Rodolfo Delfini Cancadob. Intravenous ferric carboxymaltose for the management of iron deficiency anemia. NIH. National Library of Medicine, National Center for Biotechnology Information. PMC PubMed Central. October 2015. [Accessed on 16th May 2026] 
3. American Regent, Inc. Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in treating Iron Deficiency Anemia. NIH. U.S. National Library of Medicine. ClinicalTrials.gov. [Revised in February 2018] [Accessed on 16th May 2026] 
4. Vifor France. Electronic Medicines Compendium (EMC). [Revised in November 2021] [Accessed on 16th May 2026]
5. Vifor (International) Inc., U.S. Food & Drug Administration. [Revised in April 2021] [Accessed on 16th May 2026]
Useful Diagnostic Tests
Author Details
